CP-547,632 in Treating Patients With Recurrent or Persistent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
PHASE2CompletedINTERVENTIONAL
Timeline
Start Date
December 31, 2004
Study Completion Date
February 28, 2005
Conditions
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Interventions
DRUG
CP-547,632
Trial Locations (1)
90095-1781
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles
All Listed Sponsors
collaborator
National Cancer Institute (NCI)
NIH
lead
Jonsson Comprehensive Cancer Center
OTHER
NCT00096239 - CP-547,632 in Treating Patients With Recurrent or Persistent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer | Biotech Hunter | Biotech Hunter